Speakers from Touchstone Exploration, Shanta Gold, Savannah Resources and Kavango Resources feature in our Natural Resources webinar on May 25th. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibody Share News (FAB)

Share Price Information for Fusion Antibody (FAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 150.00
Bid: 145.00
Ask: 155.00
Change: -2.50 (-1.64%)
Spread: 10.00 (6.90%)
Open: 152.50
High: 152.50
Low: 150.00
Yest. Close: 152.50
FAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Fusion Antibodies Posts Strong Annual Results As Ramps Up Services

Wed, 19th Aug 2020 09:15

(Alliance News) - Fusion Antibodies PLC on Wednesday said good annual results were owed to expanding its services, with limited affects on trading from Covid-19.

The antibody services provider posted a pretax loss for the financial year ended March 31 of GBP1.1 million, narrowing from GBP1.5 million a year prior.

Revenue increased 79% to GBP3.9 million from GBP2.2 million year on year.

Most of Fusion Antibodies' growth came from the expansion of its existing services, and most notably from the rational affinity maturation platform, or Ramp, which is the most recent addition to the company's services.

Chief Executive Paul Kerr said: "We have had a strong year with the increased revenue performance in the first and second halves driven by the expansion of our existing services and newly introduced RAMP. The company has also seen strong geographical growth in the financial year with the appointment of two new distributors in Asia as well carrying out a RAMP project for a large indigenous company in China."

The company pays no dividend.

As for the effects of Covid-19, Fusion Antibodies said it has limited the impact on trading performance, with laboratory work continuing, so that trading in for the current financial year has been in line with expectations so far and the pattern of customer payments is unchanged.

Kerr said: "Working with an international customer base presents opportunities and challenges as governments and companies respond to the immediate crisis and plan for a way forward in new circumstances.

"The board believes the company has the expertise to meet these challenges and capitalise on opportunities, and having raised capital post year end, that it also has the financial resources to face the coming months with confidence."

Fusion Antibodies shares were down 0.5% at 98.00 pence each on Wednesday morning in London.

By Greg Roxburgh; gregroxburgh@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News

TRADING UPDATES: Supreme annual revenue jumps; Pelatro in Asia deal

TRADING UPDATES: Supreme annual revenue jumps; Pelatro in Asia deal

4 May 21 19:13

IN BRIEF: Fusion Antibodies Hires Jones From BrYet To Replace CEO Kerr

IN BRIEF: Fusion Antibodies Hires Jones From BrYet To Replace CEO Kerr

16 Feb 21 14:24

Omega Diagnostics Signs Contract To Make Covid Tests; Appoints Chair

Omega Diagnostics Signs Contract To Make Covid Tests; Appoints Chair

11 Feb 21 11:16

Fusion Antibodies Half-Year Revenue Rises And Loss Narrows

Fusion Antibodies Half-Year Revenue Rises And Loss Narrows

20 Nov 20 13:25

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

13 Nov 20 16:06

IN BRIEF: Fusion Antibodies Gets Grant From Invest Northern Ireland

IN BRIEF: Fusion Antibodies Gets Grant From Invest Northern Ireland

27 Oct 20 15:15

UK DIRECTOR DEALINGS SUMMARY: Supply@Me CEO Buys GBP1 Million Option

UK DIRECTOR DEALINGS SUMMARY: Supply@Me CEO Buys GBP1 Million Option

24 Sep 20 16:35

IN BRIEF: Fusion Antibodies Surges On Virus Study Progress

IN BRIEF: Fusion Antibodies Surges On Virus Study Progress

18 Sep 20 21:16

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

18 Sep 20 15:45

Fusion Antibodies soars on Covid-19 test progress

(Sharecast News) - Fusion Antibodies shares soared after the antibody specialist said it had made progress on developing coronavirus antigen tests.

18 Sep 20 09:48

Fusion Antibodies Posts Strong Annual Results As Ramps Up Services

Fusion Antibodies Posts Strong Annual Results As Ramps Up Services

19 Aug 20 09:15

UK TRADING UPDATE SUMMARY: Codemasters On Up As Finds Right Formula

UK TRADING UPDATE SUMMARY: Codemasters On Up As Finds Right Formula

11 Aug 20 12:36

IN BRIEF: Fusion Antibodies Expects Revenue Surge Amid Pandemic

IN BRIEF: Fusion Antibodies Expects Revenue Surge Amid Pandemic

6 Jul 20 16:02

Fusion Antibodies FY revenues continue to grow in 2020

(Sharecast News) - Pre-clinical antibodies group Fusion Antibodies said on Monday that revenues had continued to grow over the year ending on 31 March.

6 Jul 20 10:41

UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE

UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE

28 Apr 20 12:28

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.